<code id='CCAE942A28'></code><style id='CCAE942A28'></style>
    • <acronym id='CCAE942A28'></acronym>
      <center id='CCAE942A28'><center id='CCAE942A28'><tfoot id='CCAE942A28'></tfoot></center><abbr id='CCAE942A28'><dir id='CCAE942A28'><tfoot id='CCAE942A28'></tfoot><noframes id='CCAE942A28'>

    • <optgroup id='CCAE942A28'><strike id='CCAE942A28'><sup id='CCAE942A28'></sup></strike><code id='CCAE942A28'></code></optgroup>
        1. <b id='CCAE942A28'><label id='CCAE942A28'><select id='CCAE942A28'><dt id='CCAE942A28'><span id='CCAE942A28'></span></dt></select></label></b><u id='CCAE942A28'></u>
          <i id='CCAE942A28'><strike id='CCAE942A28'><tt id='CCAE942A28'><pre id='CCAE942A28'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:847
          Stock exchange
          Drew Angerer/Getty Images

          Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

          In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

          advertisement

          Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          Lilly’s obesity pill cuts 15% of weight at highest dose in mid
          Lilly’s obesity pill cuts 15% of weight at highest dose in mid

          KristofferTripplaar/APSANDIEGO–AnexperimentalpillfromEliLillyledto14.7%weightlossonthehighestdoseina

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

          3:15MembersoftheWagnerGroupmilitarycompanysitatopofatankonastreetinRostov-on-Don,Russia,June24,2023,